ArticleMolecules (Basel, Switzerland)2019

Identification of High-Affinity Inhibitors of Cyclin-Dependent Kinase 2 Towards Anticancer Therapy.

Taj Mohammad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.